Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / SRDX - Surmodics down 8% on risk to SurVeil DCB study


SRDX - Surmodics down 8% on risk to SurVeil DCB study

  • Thinly traded Surmodics (SRDX -8.4%) is down on average volume, albeit turnover of only 89K shares, in response to its disclosure of an updated FDA advisory on the potential for higher rates of long-term mortality connected to the use of paclitaxel-coated balloons and paclitaxel-eluting stents to treat peripheral artery disease (PAD) in the femoropopliteal artery.
  • More news on: Surmodics, Inc., Medtronic plc, Healthcare stocks news, Stocks on the move,
  • Read more ...
Stock Information

Company Name: Surmodics Inc.
Stock Symbol: SRDX
Market: NASDAQ
Website: surmodics.com

Menu

SRDX SRDX Quote SRDX Short SRDX News SRDX Articles SRDX Message Board
Get SRDX Alerts

News, Short Squeeze, Breakout and More Instantly...